ATE178908T1

Lys (B28) insulins. Human insulin analogues

Abstract

Human insulin analogues having a positively charged amino acid residue, i.e. Lys or Arg, in position B28, i.e. in position 8 in the B-chain calculated from [Gly<sup>B20</sup>], and optionally being further modified in the C-terminal end of the B-chain from [Phe<sup>B24</sup>] to the C-terminal amino acid residue and optionally A21 and/or B3 being different from Asn as well as insulin preparations containing the human insulin analogues are provided.

Term

Term ended

Projected expiry passed 21 December 2009, 16.8 years ago.

48 members in 20 offices

This recordMember, by publication datePriority claim10 more offices are in the list below

Priority claims2

Priority claims
Document	Office	Kind	Date
721588	Denmark	A	1988-12-23
477789	Denmark	A	1989-09-28

Members48

Family members, oldest first
Document	Office	Kind
DK721588D0	Denmark	D0	1988-12-23
DK477789D0	Denmark	D0	1989-09-28
CA2006578A1	Canada	A1	1990-06-23
EP0375437A2	European Patent Office (EPO)	A2	1990-06-27
CN1043719A	China	A	1990-07-11
WO9007522A1	World Intellectual Property Organization (WIPO)	A1	1990-07-12
AU4834490A	Australia	A	1990-08-01
IL92853D0	Israel	D0	1990-09-17
ZA899501B	South Africa	B	1990-09-26
KR910700262A	Republic of Korea	A	1991-03-14
DD290426A5	German Democratic Republic (until 1990)	A5	1991-05-29
DK119391D0	Denmark	D0	1991-06-20
FI913037A7	Finland	A7	1991-06-20
NO912438D0	Norway	D0	1991-06-21
NO912438L	Norway	L	1991-08-21
DK119391A	Denmark	A	1991-08-22
EP0375437A3	European Patent Office (EPO)	A3	1991-09-11
HUT56857A	Hungary	A	1991-10-28
YU243689A	Yugoslavia, later Serbia and Montenegro (until 2006)	A	1991-10-31
NZ231936A	New Zealand	A	1992-04-28
JPH04502465A	Japan	A	1992-05-07
US5164366A	United States of America	A	1992-11-17
DK166730B	Denmark	B	1993-07-05
AU641631B2	Australia	B2	1993-09-30
DK166730C	Denmark	C	1993-11-15
NO301483B1	Norway	B1	1997-11-03
US5716927A	United States of America	A	1998-02-10
EP0837072A2	European Patent Office (EPO)	A2	1998-04-22
EP0837072A3	European Patent Office (EPO)	A3	1998-08-19
EP0861851A1	European Patent Office (EPO)	A1	1998-09-02
EP0375437B1	European Patent Office (EPO)	B1	1998-09-09
AT170875T	Austria	T	1998-09-15
ATE170875T1	Austria	T1	1998-09-15
DE68928810D1	Germany	D1	1998-10-15
EP0837072B1	European Patent Office (EPO)	B1	1999-01-20
AT175974T	Austria	T	1999-02-15
ATE175974T1	Austria	T1	1999-02-15
DE68928917D1	Germany	D1	1999-03-04
DE68928810T2	Germany	T2	1999-03-18
EP0861851B1	European Patent Office (EPO)	B1	1999-04-14
AT178908T	Austria	T	1999-04-15
ATE178908T1This record	Austria	T1	1999-04-15
DE861851T1	Germany	T1	1999-04-22
DE68928971D1	Germany	D1	1999-05-27
DE68928917T2	Germany	T2	1999-08-05
ES2134669T3	Spain	T3	1999-10-01
DE68928971T2	Germany	T2	1999-12-02
US2002013269A1	United States of America	A1	2002-01-31

2 legal events, as the office reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code
2003-09-15	Ceased due to non-payment of the annual feeCeasedREN	REN
1999-12-15	Publication of translation of european patent specificationUEP	UEP